Efficacy and Safety of Lenvatinib-based Combination Therapies for Patients with Unresectable Hepatocellular Carcinoma: a Single Center Retrospective Study.
FRONTIERS IN IMMUNOLOGY（2023）
Key words
hepatocellular carcinoma,Lenvatinib,combination therapy,PD-1,tumor-downstaging
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined